Yingde Greatchem Chemicals Co., Ltd. (SHE:300804)
China · Delayed Price · Currency is CNY 45.08
-0.77 (-1.68%)
Sep 4, 2026, 4:00 PM EDT
SHE:300804 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 737.3 | 753.53 | 722.29 | 493.49 | 657.2 | 646.55 |
Other Revenue | 0.78 | 1.27 | 1.19 | 1.52 | 2.7 | 4.61 |
| 738.08 | 754.8 | 723.48 | 495.01 | 659.9 | 651.15 | |
Revenue Growth | -8.28% | 4.33% | 46.15% | -24.99% | 1.34% | 43.95% |
Cost of Revenue | 571.64 | 574.78 | 574.73 | 377.7 | 467.92 | 446.24 |
Gross Profit | 166.44 | 180.02 | 148.76 | 117.31 | 191.98 | 204.92 |
Selling, General & Admin | 92.74 | 84.03 | 75.5 | 53.39 | 54.38 | 51.26 |
Research & Development | 35.41 | 34.51 | 38.83 | 27.07 | 28.4 | 26.51 |
Other Operating Expenses | 2.1 | 2.15 | 1.96 | 1.4 | 1.51 | 2.39 |
Operating Expenses | 129.05 | 119.84 | 119.59 | 82.93 | 87.28 | 80.78 |
Operating Income | 37.39 | 60.18 | 29.16 | 34.38 | 104.7 | 124.14 |
Interest Expense | -5.29 | -10.59 | -9.48 | -7.76 | -4.4 | -2.49 |
Interest & Investment Income | 4.78 | 7.15 | 11.46 | 7.11 | 0.09 | 0.19 |
Currency Exchange Gain (Loss) | -1.52 | -0.48 | 3 | 1.3 | 8.37 | -2.53 |
Other Non Operating Income (Expenses) | -20 | -8.17 | -6.29 | -4.41 | -4.66 | -1.08 |
EBT Excluding Unusual Items | 15.36 | 48.09 | 27.86 | 30.62 | 104.1 | 118.24 |
Gain (Loss) on Sale of Investments | 0.37 | 0.29 | 0.3 | 0.05 | - | -0.02 |
Gain (Loss) on Sale of Assets | -0.61 | -3.23 | -4.85 | -1.51 | -1.39 | -2.56 |
Asset Writedown | -2.26 | -2.26 | - | -0.8 | - | -0.88 |
Legal Settlements | - | - | - | - | -0.49 | - |
Other Unusual Items | -0.74 | -0.31 | 11.25 | 2.25 | 1.29 | 1.28 |
Pretax Income | 12.13 | 42.59 | 34.56 | 30.61 | 103.52 | 116.06 |
Income Tax Expense | -3.43 | 2.17 | 0.32 | 0.54 | 7.34 | 14.09 |
Earnings From Continuing Operations | 15.56 | 40.42 | 34.25 | 30.07 | 96.17 | 101.97 |
Minority Interest in Earnings | -0.55 | 0.3 | 0.44 | - | - | -3.77 |
Net Income | 15.01 | 40.71 | 34.68 | 30.07 | 96.17 | 98.2 |
Net Income to Common | 15.01 | 40.71 | 34.68 | 30.07 | 96.17 | 98.2 |
Net Income Growth | -64.05% | 17.39% | 15.33% | -68.73% | -2.06% | 40.74% |
Shares Outstanding (Basic) | 74 | 74 | 74 | 14 | 56 | 55 |
Shares Outstanding (Diluted) | 74 | 74 | 74 | 14 | 56 | 55 |
Shares Change | -0.06% | 0.32% | 432.48% | -75.07% | 0.20% | 4.96% |
EPS (Basic) | 0.20 | 0.55 | 0.47 | 2.17 | 1.73 | 1.77 |
EPS (Diluted) | 0.20 | 0.55 | 0.47 | 2.17 | 1.73 | 1.77 |
EPS Growth | -64.03% | 17.02% | -78.34% | 25.43% | -2.26% | 34.09% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -355.72 | -150.63 | -81.32 | -222.82 | -124.79 | 37.74 |
Free Cash Flow Per Share | -4.81 | -2.04 | -1.10 | -16.08 | -2.25 | 0.68 |
Dividend Per Share | 0.150 | 0.150 | - | 0.675 | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 22.55% | 23.85% | 20.56% | 23.70% | 29.09% | 31.47% |
Operating Margin | 5.07% | 7.97% | 4.03% | 6.94% | 15.87% | 19.06% |
Profit Margin | 2.03% | 5.39% | 4.79% | 6.08% | 14.57% | 15.08% |
Free Cash Flow Margin | -48.20% | -19.96% | -11.24% | -45.01% | -18.91% | 5.79% |
EBITDA | 114.6 | 129.32 | 92.87 | 83.13 | 137.06 | 148.25 |
EBITDA Margin | 15.53% | 17.13% | 12.84% | 16.79% | 20.77% | 22.77% |
D&A For EBITDA | 77.21 | 69.14 | 63.71 | 48.75 | 32.37 | 24.11 |
EBIT | 37.39 | 60.18 | 29.16 | 34.38 | 104.7 | 124.14 |
EBIT Margin | 5.07% | 7.97% | 4.03% | 6.94% | 15.87% | 19.06% |
Effective Tax Rate | - | 5.09% | 0.91% | 1.76% | 7.09% | 12.14% |
Revenue as Reported | 355.87 | 754.8 | 723.48 | 495.01 | 659.9 | 651.15 |